Salivary gland protection from iodine-131 therapy; evaluation of salivary stimulating tablets efficacy using 131 iodine dosimetry and salivary gland scintigraphy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88337776

Enrollment

Registered

2003-09-12

Start date

2002-03-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System: Salivation Digestive System Salivation

Interventions

Randomised test intervention versus standardised intervention, non-blinded (Phase 3).

Eligibility

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
If this study shows that SST has efficacy in salivary radioprotection then this could then be incorporated into standard radioiodine treatment protocols.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026